{
  "id": 14693986,
  "title": "Beren Therapeutics Presents New Adrabetadex Data Showing Preservation of Neurological Function for More Than 10 Years in Children with Infantile-Onset NPC",
  "url": "https://urgent.news/2026/10/15/beren-therapeutics-presents-new-adrabetadex-data-showing-preservation",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-15T12:12:58.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/beren-therapeutics-presents-new-adrabetadex-data-showing-preservation-of-neurological-function-for-more-than-10-years-in-children-with-infantile-onset-npc"
  },
  "original_language": "en",
  "account": null,
  "summary": "A case study presented at Child Neurology Society Annual Meeting demonstrates preservation of neurological function in sisters with infantile-onset Niemann-Pick disease, type C Additional data presentations reinforce benefit of early and sustained adrabetadex treatment in preserving function and improving long-term outcomes THOUSAND OAKS, Calif. — Beren Therapeutics P.B.C., a leader in…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}